Emergent BioSolutions
EBS
#8033
Rank
$0.37 B
Marketcap
$7.22
Share price
-0.55%
Change (1 day)
22.79%
Change (1 year)

Emergent BioSolutions (EBS) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : $0.79 Billion USD

According to Emergent BioSolutions 's latest financial reports the company's total liabilities are $0.79 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Emergent BioSolutions - Total liabilities on balance sheet (from 2004 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31$0.79 B-12.23%
2024-12-31$0.90 B-22.74%
2023-12-31$1.17 B-34%
2022-12-31$1.77 B32.12%
2021-12-31$1.34 B-6.27%
2020-12-31$1.43 B15.93%
2019-12-31$1.23 B1.67%
2018-12-31$1.21 B671.69%
2017-12-31$0.15 B-57.77%
2016-12-31$0.37 B-0.94%
2015-12-31$0.37 B-2.08%
2014-12-31$0.38 B180.43%
2013-12-31$0.13 B12.58%
2012-12-31$0.12 B-6.17%
2011-12-31$0.13 B2.67%
2010-12-31$0.12 B25.66%
2009-12-31$0.10 B10.32%
2008-12-31$91.43 M-10.66%
2007-12-31$0.10 B2.57%
2006-12-31$99.78 M145.8%
2005-12-31$40.59 M-11.95%
2004-12-31$46.1 M
2002-12-31$18.63 M-67.71%
2001-12-31$57.71 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
$117.21 B 14,601.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$82.75 B 10,279.28%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
$60.18 B 7,448.81%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
$3.83 M-99.52%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
$67.76 M-91.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
$55.02 M-93.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$31.80 B 3,889.46%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel